Calendar Year 2020 Sample Clauses
The 'Calendar Year 2020' clause defines the specific period from January 1, 2020, to December 31, 2020, as the relevant timeframe for the agreement or provision in which it appears. This clause is used to clarify that any obligations, rights, or calculations referenced are limited to events or data occurring within this twelve-month period. By precisely identifying the applicable year, the clause ensures clarity and prevents disputes over which time period is covered by the contract's terms.
Calendar Year 2020. Eligible bargaining unit members as defined in subsection (A), above, shall receive a retroactive two percent (2.0%) increase to their January 1, 2020 base salary payable with the June 30, 2021 pay.
Calendar Year 2020. The Company contribution will be a percentage (shown below) of the 2020 “Company Premium Caps”, which for each enrollment tier are either (1) the actual NECA Plan 16 Premiums as of January 1, 2020, for that enrollment tier or (2) the 2019 Company Premium Cap for that enrollment tier increased by 7.0%, whichever is lower. The Company contribution % of the 2020 Company Premium Caps will be 85%. The Employee contribution amount will be the remainder of the actual 2020 NECA Plan 16 Premium. Note: The NECA Plan 16 Premiums are the actual monthly premiums for the four (4) NECA Plan 16 coverage levels for any given calendar year, as determined by the FMCP (which has guaranteed a rate methodology through the end of 2020 which pools the various plans offered by the FMCP as one group for rate increase computation purposes).
Calendar Year 2020. In the event BII elects to extend the Research Period pursuant to Section 3.2.2 (Extension), any additional Research Funding from BII to Epizyme as consideration for the costs to be incurred by Epizyme in connection with: (i) performing Research Activities not completed by Epizyme under the prior Research Plan that BII desires for Epizyme to continue during Calendar Year 2020; and (ii) any additional Research Activities not already covered under the existing Research Plan (if any) undertaken pursuant to any revisions made to the Research Plan for Calendar Year 2020, with respect to (i)-(ii), and the timing of such payments, shall be agreed to by the Parties pursuant to Section 3.2.2 (Extension; provided that, with respect to (i)-(ii), BII shall be allowed to credit against any such additional Research Funding an amount equal to the total budget of [**] Dollars ($[**]) that Epizyme has allocated for its performance of Research Activities under the Research Plan in Calendar Year 2019, minus the expenses Epizyme actually incurred in connection with the performance of such activities, and BII shall make such payments in accordance with such payment schedule.